Computer-aided design of liposomal drugs: In silico prediction and experimental validation of drug candidates for liposomal remote loading.
暂无分享,去创建一个
Amiram Goldblum | Alexander Tropsha | Yechezkel Barenholz | Ahuva Cern | A. Tropsha | A. Goldblum | Y. Barenholz | Ahuva Cern
[1] Bradley D Anderson,et al. Enhanced active liposomal loading of a poorly soluble ionizable drug using supersaturated drug solutions. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[2] G. Betageri,et al. Development and Stability Studies of Novel Liposomal Vancomycin Formulations , 2012, ISRN pharmaceutics.
[3] M. Yeh,et al. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy , 2011, International journal of nanomedicine.
[4] Gregory Gregoriadis,et al. Liposome Technology, Volume I: Liposome Preparation and Related Techniques, Third Edition , 2006 .
[5] Alexander Golbraikh,et al. Quantitative structure-property relationship modeling of remote liposome loading of drugs. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[6] H. Maeda,et al. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] Alexander Golbraikh,et al. Predictive QSAR modeling workflow, model applicability domains, and virtual screening. , 2007, Current pharmaceutical design.
[8] Young Jik Kwon,et al. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[9] Y. Barenholz,et al. Liposomes: preparation, characterization, and preservation. , 2006 .
[10] Y. Barenholz,et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. , 1994, Cancer research.
[11] Yechezkel Barenholz,et al. Enzymatic assays for quality control and pharmacokinetics of liposome formulations: comparison with nonenzymatic conventional methodologies. , 2003, Methods in enzymology.
[12] Jean-Christophe Leroux,et al. Development and physico-chemical characterization of a liposomal formulation of istaroxime. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[13] Liang Fang,et al. Formulation and characterization of boanmycin-loaded liposomes prepared by pH gradient experimental design , 2012, Drug delivery.
[14] Chan-Wha Kim,et al. Pharmacokinetic Profiles of Two Branded Formulations of Piroxicam 20mg in Healthy Korean Volunteers by a Rapid Isocratic HPLC Method , 2009 .
[15] Y. Barenholz,et al. Optimization and upscaling of doxorubicin-containing liposomes for clinical use. , 1990, Journal of pharmaceutical sciences.
[16] E. Chan,et al. Development of stealth liposome coencapsulating doxorubicin and fluoxetine , 2011, Journal of liposome research.
[17] Y. Barenholz. Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[18] Hitoshi Sasaki,et al. Fluorescence investigation of the retinal delivery of hydrophilic compounds via liposomal eyedrops. , 2011, Biological & pharmaceutical bulletin.
[19] K A Pappa,et al. The clinical development of mupirocin. , 1990, Journal of the American Academy of Dermatology.
[20] S. Clerc,et al. Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. , 1995, Biochimica et biophysica acta.
[21] Ola. M. Abdallah. RP-HPLC Determination of Three Anti-Hyperlipidemic Drugs in Spiked Human Plasma and in Dosage Forms , 2011 .
[22] J. Li,et al. In vitro and in vivo evaluation of sanguinarine liposomes prepared by a remote loading method with three different ammonium salts. , 2011, Die Pharmazie.
[23] E. Azzopardi,et al. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. , 2013, The Journal of antimicrobial chemotherapy.
[24] Takuya Fujisawa,et al. Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[25] Y. Barenholz,et al. Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies. , 1989, Biochimica et biophysica acta.
[26] Volker Wagner,et al. The emerging nanomedicine landscape , 2006, Nature Biotechnology.
[27] Y. Barenholz,et al. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. , 1993, Biochimica et biophysica acta.
[28] Qiang Yu,et al. Loading 3-deazaneplanocin A into pegylated unilamellar liposomes by forming transient phenylboronic acid-drug complex and its pharmacokinetic features in Sprague-Dawley rats. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Xiaoju Zhou,et al. Novel liposomal gefitinib (L-GEF) formulations. , 2012, Anticancer research.
[30] Gert Storm,et al. Liposomal pravastatin inhibits tumor growth by targeting cancer-related inflammation. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[31] Yechezkel Barenholz,et al. Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy , 2003, Journal of liposome research.
[32] Amiram Goldblum,et al. Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties. , 2009, Journal of controlled release : official journal of the Controlled Release Society.